Fructose-1,6-diphosphate inhibits seizure acquisition in fast hippocampal kindling

Neuroscience Letters

Volumn 477, Issue 1, 2010, Pages 33-36

  Ding, Yao ^a   Wang, Shuang ^a   Zhang, Man man ^a   Guo, Yi ^a   Yang, Yi ^a   Weng, Shu qun ^a   Wu, Ji min ^a   Qiu, Xia ^a   Ding, Mei ping ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Antiepileptogenic; Fructose 1,6 diphosphate; Glycolytic metabolism; Hippocampal kindling; Rat

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; FRUCTOSE 1,6 BISPHOSPHATE; MESSENGER RNA;

AFTERDISCHARGE; AFTERDISCHARGE DURATION; AFTERDISCHARGE THRESHOLD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; DISEASE SEVERITY; DRUG MEGADOSE; GENE EXPRESSION; HIPPOCAMPUS; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SEIZURE; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; FRUCTOSEDIPHOSPHATES; KINDLING, NEUROLOGIC; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, TRKB; RNA, MESSENGER; SEIZURES; SIGNAL TRANSDUCTION;

EID: 77953126194     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.04.030     Document Type: Article

References (23)

1. Bailey E.E., Pfeifer H.H., Thiele E.A. The use of diet in the treatment of epilepsy. Epilepsy Behav. 2005, 6:4-8.
2. Bertram E. The relevance of kindling for human epilepsy. Epilepsia 2007, 48(Suppl. 2):65-74.
3. Binder D.K., Croll S.D., Gall C.M., Scharfman H.E. BDNF and epilepsy: too much of a good thing?. Trends Neurosci. 2001, 24:47-53.
4. Binder D.K., Routbort M.J., Ryan T.E., Yancopoulos G.D., McNamara J.O. Selective inhibition of kindling development by intraventricular administration of TrkB receptor body. J. Neurosci. 1999, 19:1424-1436.
5. Canals J.M., Checa N., Marco S., Michels A., Perez-Navarro E., Alberch J. The neurotrophin receptors trkA, trkB and trkC are differentially regulated after excitotoxic lesion in rat striatum. Brain Res. Mol. Brain Res. 1999, 69:242-248.
6. Chen Q, He S., Hu X.L., Yu J., Zhou Y., Zheng J., Zhang S., Zhang C., Duan W.H., Xiong Z.Q. Differential roles of NR2A- and NR2B-containing NMDA receptors in activity-dependent brain-derived neurotrophic factor gene regulation and limbic epileptogenesis. J. Neurosci. 2007, 27:542-552.
7. Garriga-Canut M., Schoenike B., Qazi R., Bergendahl K., Daley T.J., Pfender R.M., Morrison J.F., Ockuly J., Stafstrom C., Sutula T., Roopra A. 2-Deoxy-d-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat. Neurosci. 2006, 9:1382-1387.
8. Kim do Y., Rho J.M. The ketogenic diet and epilepsy. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11:113-120.
9. Kokaia M., Ernfors P., Kokaia Z., Elmer E., Jaenisch R., Lindvall O. Suppressed epileptogenesis in BDNF mutant mice. Exp. Neurol. 1995, 133:215-224.
10. Koyama R., Ikegaya Y. To BDNF or not to BDNF: that is the epileptic hippocampus. Neuroscientist 2005, 11:282-287.
11. Lian X.Y., Khan F.A., Stringer J.L. Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats. J. Neurosci. 2007, 27:12007-12011.
12. Lothman E.W., Williamson J.M. Closely spaced recurrent hippocampal seizures elicit two types of heightened epileptogenesis: a rapidly developing, transient kindling and a slowly developing, enduring kindling. Brain Res. 1994, 649:71-84.
13. Morimoto K, Fahnestock M., Racine R.J. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog. Neurobiol. 2004, 73:1-60.
14. Nanobashvili Z., Chachua T., Nanobashvili A., Bilanishvili I., Lindvall O., Kokaia Z. Suppression of limbic motor seizures by electrical stimulation in thalamic reticular nucleus. Exp. Neurol. 2003, 181:224-230.
15. Watson C., Paxinos G. The Rat Brain in Stereotaxic Coordinates 2004, Academic Press, New York.
16. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972, 32:281-294.
17. Riedel B.J., Gal J., Ellis G., Marangos P.J., Fox A.W., Royston D. Myocardial protection using fructose-1,6-diphosphate during coronary artery bypass graft surgery: a randomized, placebo-controlled clinical trial. Anesth. Analg. 2004, 98:20-29. (table of contents).
18. Scharfman H.E., Goodman J.H., Sollas A.L., Croll S.D. Spontaneous limbic seizures after intrahippocampal infusion of brain-derived neurotrophic factor. Exp. Neurol. 2002, 174:201-214.
19. Stafstrom C.E., Roopra A., Sutula T.P. Seizure suppression via glycolysis inhibition with 2-deoxy-d-glucose (2DG). Epilepsia 2008, 49(Suppl. 8):97-100.
20. Stringer J.L., Xu K. Possible mechanisms for the anticonvulsant activity of fructose-1,6-diphosphate. Epilepsia 2008, 49(Suppl. 8):101-103.
21. Wu G., Fang Y.Z., Yang S., Lupton J.R., Turner N.D. Glutathione metabolism and its implications for health. J. Nutr. 2004, 134:489-492.
22. Xu K., Stringer J.L. Pharmacokinetics of fructose-1,6-diphosphate after intraperitoneal and oral administration to adult rats. Pharmacol. Res. 2008, 57:234-238.
23. Zetterstrom T.S., Pei Q., Grahame-Smith D.G. Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. Brain Res. Mol. Brain Res. 1998, 57:106-110.